Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-07-27

Clinical Trial Update: Sodium Bicarbonate in Preventing Contrast Induced Nephropathy [NA]

View source ↗

Summary

Clinical trial update on using sodium bicarbonate to prevent contrast-induced nephropathy; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Contrast Induced Nephropathy | NA | Status: COMPLETED